Table.
Region-wise colorectal cancer burden in 2019
| Incidence (95% UI) | Mortality (95% UI) | DALYs (95% UI) | Age-standardised incidence rate (95% UI) | Age-standardised mortality rate (95% UI) | Age-standardised DALY rate (95% UI) | |
|---|---|---|---|---|---|---|
| Global | 2 166 168 (1 996 298–2 342 842) | 1 085 797 (1 002 795–1 149 679) | 24 284 087 (22 614 920–25 723 221) | 26·7 (24·6–28·9) | 13·7 (12·6–14·5) | 295·5 (275·2–313·0) |
| Andean Latin America | 11 094 (8935–13 467) | 5630 (4593–6791) | 125 578 (101 753–151 796) | 20·0 (16·1–24·2) | 10·3 (8·4–12·4) | 220·8 (179·0–266·3) |
| Australasia | 23 671 (19 439–28 848) | 8382 (7575–8978) | 163 248 (150 872–173 959) | 48·3 (39·6–59·1) | 16·2 (14·8–17·3) | 348·6 (324·2–370·7) |
| Caribbean | 13 813 (11 813–15 959) | 7995 (6935–9176) | 172 016 (147 186–200 175) | 26·7 (22·9–30·9) | 15·5 (13·4–17·7) | 333·3 (285·2–387·9) |
| Central Asia | 10 949 (9999–12 008) | 7467 (6822–8166) | 199 841 (182 012–219 941) | 15·2 (13·9–16·6) | 11·2 (10·3–12·2) | 256·8 (234·4–281·1) |
| Central Europe | 84474 (74 551–95 453) | 51 567 (45 636–57 749) | 1 052 146 (922 923–1 184 246) | 39·9 (35·2–45·1) | 23·6 (20·8–26·4) | 512·6 (448·7–577·9) |
| Central Latin America | 37 542 (32 211–43 870) | 22 470 (19 542–25 997) | 539 638 (465 200–627 069) | 15·9 (13·7–18·6) | 9·7 (8·4–11·2) | 223·7 (193·1–259·5) |
| Central sub-Saharan Africa | 3957 (3015–5113) | 3544 (2705–4609) | 100 988 (75 749–131 447) | 7·7 (5·9–10·1) | 7·4 (5·7–9·9) | 169·3 (129·2–220·2) |
| East Asia | 637 096 (548 895–738 549) | 275 604 (238 238–317 886) | 6 712 862 (5 774 277–7 735 907) | 30·9 (26·8–35·7) | 14·1 (12·2–16·2) | 325·2 (280·7–373·2) |
| Eastern Europe | 106 017 (96 250–117 074) | 63 476 (57 180–70 011) | 1 419 105 (1 287 540–1 571 374) | 31·1 (28·2–34·4) | 18·3 (16·5–20·2) | 423·7 (384·0–469·3) |
| Eastern sub-Saharan Africa | 14 227 (12 130–16 886) | 12 717 (10 940–15 001) | 356 433 (301 931–425 606) | 8·8 (7·6–10·4) | 8·5 (7·4–9·9) | 193·9 (166·0–229·6) |
| High-income Asia Pacific | 196 371 (166 417–225 643) | 76 929 (64 821–83 603) | 1 327 823 (1 186 117–1 414 814) | 44·6 (38·4–51·1) | 15·3 (13·4–16·4) | 323·9 (298·6–342·1) |
| High-income North America | 260 911 (229 909–295 693) | 95 664 (88 321–99 688) | 1 987 109 (1 895 869–2 059 774) | 42·7 (37·6–48·6) | 14·9 (13·9–15·5) | 339·9 (325·9–351·9) |
| North Africa and Middle East | 60 010 (53 354–67 555) | 39 147 (34 761–44 107) | 1 013 634 (896 161–1 146 526) | 13·9 (12·3–15·6) | 9·8 (8·7–11) | 218·7 (194·1–246·5) |
| Oceania | 691 (555–855) | 551 (443–682) | 16 315 (12 915–20 556) | 10·0 (8·2–12·1) | 8·8 (7·2–10·7) | 203·6 (163·6–252·5) |
| South Asia | 113 711 (98 190–129 352) | 94 846 (81 524–109 075) | 2 419 098 (2 078 019–2 782 570) | 8·3 (7·2–9·4) | 7·3 (6·2–8·3) | 165·1 (141·7–189·9) |
| Southeast Asia | 117 010 (96 631–136 244) | 82 024 (67 617–94 606) | 2 142 434 (1 780 490–2 482 287) | 19·3 (16–22·4) | 14·4 (11·9–16·6) | 334·0 (276·6–386·4) |
| Southern Latin America | 26 866 (21 480–33 612) | 17 930 (16 774–18 975) | 366 436 (347 729–385 441) | 32·2 (25·7–40·4) | 21·2 (19·9–22·4) | 447·6 (424·7–470·5) |
| Southern sub-Saharan Africa | 7106 (6389–7882) | 5922 (5329–6580) | 147 780 (132 439–165 539) | 13·1 (11·8–14·5) | 11·5 (10·4–12·7) | 250·4 (225·1–279·3) |
| Tropical Latin America | 42 891 (40 118–44 928) | 27 704 (25 668–29 090) | 660 129 (625 562–687 740) | 17·8 (16·6–18·6) | 11·7 (10·8–12·3) | 268·3 (253·7–279·8) |
| Western Europe | 382 442 (332 800–432 448) | 172 454 (155 345–181 815) | 3 008 234 (2 815 060–3 152 895) | 42·4 (37·1–48·3) | 17·3 (15·8–18·1) | 351·2 (332·0–366·8) |
| Western sub-Saharan Africa | 15 321 (12 895–17 824) | 13 773 (11 698–16 069) | 353 242 (295 571–420 704) | 8·7 (7·4–10·0) | 8·4 (7·3–9·7) | 176·1 (149·0–206·2) |
Numbers in parenthesis represent 95% uncertainty intervals (UIs). DALYs=disability-adjusted life years. The age-standardised incidence rate, age-standardised mortality rate, and age-standardised DALY rate are shown per 100 000 person-years. Source: Global Burden of Diseases, Injuries, and Risk Factors Study 2019.